⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARTL News
Artelo Biosciences, Inc. Common Stock
Form 8-K
sec.gov
ARTL
Artelo Biosciences Announces Results from a Nonclinical Osteoarthritis Study Supporting ART26.12 as a Potential First-in-Class New Therapy for Chronic Pain Conditions
globenewswire.com
ARTL
Artelo Biosciences Issues Reminder to Shareholders to Vote in Advance of Annual Meeting on July 17, 2026
globenewswire.com
ARTL
Artelo Biosciences Announces Positive Results with ART27.13 in a Nonclinical Model of Paclitaxel-Induced Peripheral Neuropathy
globenewswire.com
ARTL
Artelo Biosciences Announces New Data Supporting ART26.12 as a Potential First-in-Class Therapy for Chronic Pain associated with Spinal Cord Injury
globenewswire.com
ARTL
Artelo Biosciences Presents Evidence for a Common Lipid-Signaling Link Across Multiple Potential Indications for Its FABP5 Inhibitor Platform at ICRS 2026
globenewswire.com
ARTL
Artelo Biosciences Presents Clinical and Biomarker Data Supportive of the Development of ART26.12 and Follow-On FABP5 Inhibitors at ICRS 2026
globenewswire.com
ARTL
Artelo Biosciences Presents ART26.12 Human Metabolite Data Demonstrating Favorable Drug Metabolism Characteristics Associated with Clinical Development Success
globenewswire.com
ARTL
Form 8-K
sec.gov
ARTL
Form 8-K
sec.gov
ARTL